Summary
- Current Price
- As of today, TARA price is $5.20, up +0.97% on
- Current Price All-Time High
- TARA price is currently -99.35% below its historical high of $800.00 set on
- Market Cap
- TARA current market cap is $286M, up +137.09% over the past 365 days
- PE Ratio
- TARA PE ratio is unknown
- Revenue
- TARA current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for TARA is on
Profile
| Metric | Value |
|---|---|
| Full Name | Protara Therapeutics, Inc. |
| Ticker | NASDAQ: TARA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | protaratx.com |
| Employees | 28 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.20 | ||
| Price, 1D Change | +0.97% | |
| $286M | ||
| - | ||
| - | ||
| 1.24 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.34 | ||
| EPS, 1Y Change | +38.08% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:40 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PRTO | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.34 | ||
| EPS Estimate | N/A | -$1.54 |
| EPS Est. Change | N/A | -14.52% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $5.20 | ||
| Price Target | - | $26.00 |
| Price Tgt. Change | - | +400.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.20 | -$2.17 | +1.56% | |
| -$1.26 | -$1.34 | -6.29% | |
| -$1.54 | N/A | -14.52% | |
| -$1.39 | N/A | -3.68% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $25.33M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +66.13% | ||
| +59.02% | ||
| +137.09% | ||
| +674.30% | ||
| 0.00% | ||
| 0.00% | ||
| +38.08% | ||
| +77.11% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $5.20 | ||
| $5.11 | ||
| SMA 200 vs Price | -1.78% | |
| $5.30 | ||
| SMA 50 vs Price | +1.84% | |
| 1.24 | ||
| $0.29 | ||
| 47.10 | ||
| 45.25% | ||
| 79.46% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.34 | ||
| -$362.00K | ||
| - | ||
| -$64.55M | ||
| - | ||
| -$57.44M | ||
| - | ||
| -$64.19M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 14.58 | ||
| 14.58 | ||
| - | ||
| - | ||
| 10.97 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.46 | ||
| -2.10 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $196.41M | ||
| $155.55M | ||
| $209.47M | ||
| $159.50M | ||
| $13.06M | ||
| $10.94M | ||
| $3.36M | ||
| $1.24M | ||
| $3.47M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $57.44M | ||
| $64.19M | ||
| $362.00K | ||
| $0.00 | ||
| $362.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$56.37M | ||
| -$139.49M | ||
| $82.72M | ||
| $94.00K | ||
| -$56.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| JP Morgan | ||
| HC Wainwright & Co. | → | |
| Piper Sandler | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Jones Trading | ||
| HC Wainwright & Co. | → | |
| Scotiabank | ||
| Cantor Fitzgerald |
Analyst sentiment
Institutional ownership
Screeners with TARA
FAQ
What is the ticker symbol for Protara Therapeutics, Inc.?
The ticker symbol for Protara Therapeutics, Inc. is NASDAQ:TARA
Does Protara Therapeutics, Inc. pay dividends?
No, Protara Therapeutics, Inc. does not pay dividends
What sector is Protara Therapeutics, Inc. in?
Protara Therapeutics, Inc. is in the Healthcare sector
What industry is Protara Therapeutics, Inc. in?
Protara Therapeutics, Inc. is in the Biotechnology industry
What country is Protara Therapeutics, Inc. based in?
Protara Therapeutics, Inc. is headquartered in United States
When did Protara Therapeutics, Inc. go public?
Protara Therapeutics, Inc. initial public offering (IPO) was on October 22, 2014
Is Protara Therapeutics, Inc. in the S&P 500?
No, Protara Therapeutics, Inc. is not included in the S&P 500 index
Is Protara Therapeutics, Inc. in the NASDAQ 100?
No, Protara Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Protara Therapeutics, Inc. in the Dow Jones?
No, Protara Therapeutics, Inc. is not included in the Dow Jones index
When was Protara Therapeutics, Inc. last earnings report?
Protara Therapeutics, Inc.'s most recent earnings report was on November 10, 2025
When does Protara Therapeutics, Inc. report earnings?
The next expected earnings date for Protara Therapeutics, Inc. is May 15, 2026
Data Sources & References
- TARA Official Website www.protaratx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1359931/000121390026025433/0001213900-26-025433-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1359931/000121390026025433/0001213900-26-025433-index.htm
- TARA Profile on Yahoo Finance finance.yahoo.com/quote/TARA
- TARA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tara
